Full Text
Agreement Between FDA Approved Drug Label and Performance-Based Risk-Sharing Arrangement Endpoints

Abstract

Authors

NN Pham JJ Carlson

Back to Volume 21, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×